Literature DB >> 7442131

Heymann nephritis induced by kidney brush border glycoproteins.

A Miettinen, T Törnroth, I Tikkanen, I Virtanen, E Linder.   

Abstract

Heymann nephritis developed in rats immunized with brush border membrane fractions isolated from rat kidney tubules. Glomerular autoantibodies eluted from cryostat sections of nephritic kidneys reacted in immunoelectron microscopy with the outer surface of isolated brush border membrane vesicles. This indicates that the autoantigens are plasma membrane components. To characterize further the chemical nature of the nephritogenic autoantigens, we treated the brush border membranes with trypsin and sodium deoxycholate, and the solubilized membranes were then fractionated by lectin affinity chromatography. The polypeptide composition of the fractions was analyzed by polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate. The capacity of the membrane fractions to induce Heymann nephritis was assessed by observing the development of typical renal lesions, antibrush border autoantibodies, and proteinuria in rats immunized with these fractions. The results suggest that the nephritogenic autoantigen is an integral component of the brush border membrane of kidney proximal tubules and has an affinity for Lens culinaris agglutinin. This indicates that it is a glycoprotein and has mannosyl and/or glycosyl groups exposed in its oligosaccharide side chains.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7442131

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  16 in total

Review 1.  Molecular development of immune deposits and proteinuria in Heymann nephritis.

Authors:  D Kerjaschki
Journal:  Clin Investig       Date:  1993-10

Review 2.  Molecular analysis of the pathological autoimmune antigens of Heymann nephritis.

Authors:  M G Farquhar
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

3.  Identification of a 400-kd protein in the brush borders of human kidney tubules that is similar to gp330, the nephritogenic antigen of rat Heymann nephritis.

Authors:  D Kerjaschki; R Horvat; S Binder; M Susani; G Dekan; P P Ojha; P Hillemanns; W Ulrich; U Donini
Journal:  Am J Pathol       Date:  1987-10       Impact factor: 4.307

4.  Trisomy 7 in non-neoplastic tubular epithelial cells of the kidney.

Authors:  S Knuutila; M L Larramendy; P Elfving; W el-Rifai; A Miettinen; F Mitelman
Journal:  Hum Genet       Date:  1995-02       Impact factor: 4.132

5.  Decrease of glomerular disialogangliosides in puromycin nephrosis of the rat.

Authors:  H Holthöfer; J Reivinen; M L Solin; A Haltia; A Miettinen
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

6.  Mapping rat megalin: the second cluster of ligand binding repeats contains a 46-amino acid pathogenic epitope involved in the formation of immune deposits in Heymann nephritis.

Authors:  A Saito; H Yamazaki; K Rader; A Nakatani; R Ullrich; D Kerjaschki; R A Orlando; M G Farquhar
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

7.  Pathogenic antibodies inhibit the binding of apolipoproteins to megalin/gp330 in passive Heymann nephritis.

Authors:  D Kerjaschki; M Exner; R Ullrich; M Susani; L K Curtiss; J L Witztum; M G Farquhar; R A Orlando
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

8.  A simple technique for detecting the antigen of Heymann nephritis in glomeruli by immunofluorescence.

Authors:  S P Makker; D M Makker
Journal:  Clin Exp Immunol       Date:  1986-06       Impact factor: 4.330

9.  Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.

Authors:  M Susani; M Schulze; M Exner; D Kerjaschki
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

10.  Lymph node cells from rats with Heymann's nephritis produce in vitro autoantibodies directed against purified renal tubular antigen.

Authors:  E de Heer; M R Daha; L A van Es
Journal:  Immunology       Date:  1984-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.